Molecular Biometrics’ collaborators in Amsterdam have published a groundbreaking article based on NIR spectroscopic analysis of embryo culture media to assess embryo reproductive potential. “This marks the culmination of a tremendous collaborative effort,” says Molecular Biometrics CEO, Dr. Jim Posillico. The article entitled, "Metabolomic profiling by near-infrared spectroscopy as a tool to assess embryo viability: a novel, non-invasive method for embryo selection", can be found at the following link.
The publication can be found here

Genetic Engineering & Biotechnology News reporter, Carol Potera talks with Molecular Biometrics’ CEO, Jim Posillico, Ph.D., about the use of NIR Spectroscopy to detect embryo viability. GEN is a leading biotech trade journal, reaching over 215,000 readers, that reports on the advances that drive research, innovation, and product development in biotechnology. This is great publicity for MB and is yet another opportunity to acquaint our peers and potential customers with the technology platform and applications.
The publication can be found here

James Posillico, PhD, President and Chief Executive Officer of Molecular Biometrics, has been invited to present at the 2008 Wharton Health Care Business Conference, a leading health care forum for industry professionals, academics and students.
The publication can be found here

Non-invasive metabolomic profiling of human embryo culture media using Raman spectroscopy predicts embryonic reproductive potential: a prospective blinded pilot study.
The publication can be found here

Molecular Biometrics (MB) is proud to announce that a paper by Dr. Emre Seli, et. al. has been accepted for publication in the November issue of the journal Fertility and Sterility. This publication marks the first paper in a peer-reviewed journal based on MB's technology platform. This is a significant achievement which reflects an understanding and acceptance of the MB technology platform by the scientific community and industry leaders.
The publication can be found here

New non-invasive screening techniques aim to identify the healthiest embryos.
The publication can be found here

Molecular Biometrics' CEO discusses plans to develop Neurodegenerative diagnostics
The publication can be found here

The success rates for in vitro fertilization are rather low. Molecular Biometrics
helps to improve the outcomes of IVF with a diagnostic that determines embryo health.
The publication can be found here